The Revvity GSP Neonatal Thyroxine (T4) assay is used with dried blood spot specimens as an aid in screening newborns for congenital hypothyroidism.
Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.
Congenital hypothyroidism (CH) results from a failure of the thyroid glands to produce thyroid hormones in adequate amounts. The condition can easily be treated with daily doses of thyroid hormones but clinical diagnosis is difficult to establish and the disease may continue unrecognized for a long time causing irreversible brain damage. However, increased thyroid stimulating hormone (hTSH) and decreased thyroxine are clear signs of CH, which have led to the establishment of large scale screening programs.
GSP Neonatal Thyroxine (T4) assay:
All Revvity neonatal products may not be available in all countries.
Application |
Newborn Screening
|
---|---|
Assay Technology |
DELFIA
|
Brand |
GSP®
|
Calibration Standards |
Yes
|
Detection Method |
DELFIA
|
Disorders |
Congenital Hypothyroidism
|
Quantity in a Package Amount |
1152.0 Units
|
Unit Size |
1 Kit
|
Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.
We are here to answer your questions.